Sign in to follow
Search Results

0 results for 'Valeant Pharmaceuticals International Inc'

You can use to get even better search results
January 21, 2020 | Litigation Daily

Report: Investors Targeted Lawsuits at Cannabis Companies in 2019

According to NERA Economic Consulting's annual report, released on Tuesday, six lawsuits alleged securities fraud against cannabis companies. There was only one in 2018.
3 minute read
January 21, 2020 | Law.com

Investors Targeted Lawsuits at Cannabis Companies in 2019, Report Finds

According to NERA Economic Consulting's annual report, released on Tuesday, six lawsuits alleged securities fraud against cannabis companies. There was only one in 2018.
3 minute read
December 17, 2019 | Law.com

Robbins Geller and Simpson Thacher Hammer Out $1.2B Valeant Settlement

Plaintiffs alleged the company now known as Bausch Health had "formed a secret network of so-called specialty pharmacies to artificially inflate the sale of Valeant drugs using a variety of fraudulent practices."
3 minute read
December 17, 2019 | Litigation Daily

Daily Dicta: Robbins Geller; Simpson Thacher Hammer Out $1.2B Valeant Settlement

"Resolving this action enables Bausch Health to close the door on one of the more meaningful and unpredictable liabilities associated with the legacy Valeant era," said the company's CEO.
3 minute read
September 09, 2019 | New York Law Journal

Second Circuit Affirms Dismissal in Class Action Targeting 'Passive' Concentration of Investments

A three-judge panel of the Second Circuit held that Sequoia's investment policy allowed for "passive" changes in value that propelled the fund's position in the health care industry to exceed the threshold following its initial investment.
3 minute read
February 28, 2019 | Corporate Counsel

Tesla, CBS and United See New General Counsel: February 2019 In-House Moves

A roundup of major in-house moves occurring in February.
11 minute read
February 20, 2019 | National Law Journal

Katten Muchin Disqualified From 3 Mylan Appeals

Firm's interpretation of key provision in Valeant Pharmaceuticals engagement letter is "irrational," appellate court rules.
4 minute read
December 03, 2018 | Corporate Counsel

Righting the Ship: GC Christina Ackermann's Efforts to Rebuild at Bausch Health

When Christina Ackermann came onboard in August 2016, Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, was in distress. But she said she knew what she was signing up for: Rebuilding Bausch's governance structure and reshaping her legal department, while helping the business side dig out of a dark financial hole.
5 minute read
September 13, 2018 | National Law Journal

Valeant, Mylan Go to War Over Katten Disqualification

Valeant's attempt to disqualify a team of Katten Muchin Rosenman patent litigators led to a showdown Wednesday at the Federal Circuit.
9 minute read
September 13, 2018 | Litigation Daily

Mylan, Valeant Go to War Over Katten Disqualification

Valeant's attempt to disqualify a team of Katten Muchin Rosenman patent litigators led to a showdown Wednesday at the Federal Circuit.
9 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now